Relationship between lipid composition and antibiotic-resistance to isoniazid, streptomycin, p-aminosalicylic acid, ethambutol, rifampicin in mycobacteria
- PMID: 962981
Relationship between lipid composition and antibiotic-resistance to isoniazid, streptomycin, p-aminosalicylic acid, ethambutol, rifampicin in mycobacteria
Abstract
The content of neutral lipids, peptido-glycolipids and phospholipids, separated by solvent extractions and TLC, was investigated and compared in various strains of Mycobacterium tuberculosis and in Mycobacterium avium. The examined strains could be divided into two groups: (i) those possessing a stable INH-resistance with a chromosomal location for the resistance genes, in which the content of total lipids and the distribution of lipid subfractions were modified with respect to the control strain H37Rv; (ii) those strains, such as the mutants resistant to streptomycin (Sm), ethambutol (EM), p-aminosalicylic acid (PAS) and rifampicin (R/AMP), uncorrelated drugs with different genetic location of the antibiotic-resistance, in which a disturbance of the lipid metabolism does not appeared to be significant. TLC and chemical analysis of INH-mutants suggested that the decrease of the cell lipids was associated with the peptidoglyco-phospholipid fraction, while the neutral lipids were characterized by a most elevated amount of both menaquinone-9 and free fatty acids, and by comparable levels of both glycerides and total fatty acids with respect to the sensitive strain. In the pattern of fatty acid shorter than C26 of all the fractions studied, no significant differences were observed between the H37Rv strain and the other resistant strains, including the M. avium. In the course of the lipid analysis no unusual phospholipids in addition to CL, PE and phosphatidylinositol-oligo-mannoside (PIM) were detected. Reasoning in a speculative way, the dramatic fall of the complex lipid elaboration in the INH-resistant mycobacteria, may underline a role for these substances in the envelope of the mycobacterial cell that defends itself from the selecting attack of the antibiotic molecule and that keeps this phenotypic expression of INH-resistance in the mutants.
Similar articles
-
Mutational studies of the drug-resistance of M. tuberculosis with special reference to p-aminosalicylic acid, ethambutol, isoniazid and rifampicin.Boll Ist Sieroter Milan. 1975;54(6):437-44. Boll Ist Sieroter Milan. 1975. PMID: 816363
-
[Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].Acta Biol Med Ger. 1973;30(3):309-16. Acta Biol Med Ger. 1973. PMID: 4202698 German. No abstract available.
-
A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.Med J Malaysia. 1993 Jun;48(2):113-6. Med J Malaysia. 1993. PMID: 8350784
-
Studies on the role of the mycobacterial cell envelope in the multiple drug resistance of atypical mycobacteria.Res Microbiol. 1991 May;142(4):448-51. doi: 10.1016/0923-2508(91)90119-u. Res Microbiol. 1991. PMID: 1871432 Review. No abstract available.
-
Lipid metabolism in mycobacteria--Insights using mass spectrometry-based lipidomics.Biochim Biophys Acta. 2016 Jan;1861(1):60-67. doi: 10.1016/j.bbalip.2015.10.007. Epub 2015 Oct 26. Biochim Biophys Acta. 2016. PMID: 26515252 Review.
Cited by
-
Detection of Species-Specific Lipids by Routine MALDI TOF Mass Spectrometry to Unlock the Challenges of Microbial Identification and Antimicrobial Susceptibility Testing.Front Cell Infect Microbiol. 2021 Feb 4;10:621452. doi: 10.3389/fcimb.2020.621452. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33634037 Free PMC article. Review.
-
Investigations into Isoniazid Treated Mycobacterium tuberculosis by Electrospray Mass Spectrometry Reveals New Insights into Its Lipid Composition.J Pathog. 2018 Jun 19;2018:1454316. doi: 10.1155/2018/1454316. eCollection 2018. J Pathog. 2018. PMID: 30018826 Free PMC article.